SCOTTSDALE, AZ--(Marketwire - October 31, 2007) - Medistem Laboratories (OTCBB: MDSM) announced today that Thomas Ichim, Chief of Scientific Development, will present a company update at the 9th Annual Acumen BioFin Rodman & Renshaw conference in New York on Monday, November 5, 2007 at 10:55 a.m. eastern time (ET). Ichim’s talk will address recent results from Medistem’s basic research and pre-clinical activities surrounding the Tolerostem and Angiostem platforms; along with other company developments.
